The Zensights Federated Healthcare Advisory Panel explores how shifting global dynamics are reshaping access and strategic ...

Sheeran continues the conversation on the collaboration between AWS and EVERSANA in the second part of this interview.

Capan discusses the collaboration between AWS and EVERSANA in the first part of this two-part interview.

Market access is about aligning internal strategies with external realities that often change without warning and at a ...

Fran Gregory, VP, emerging therapies, Cardinal Health, discusses the evolving cell and gene therapy landscape, highlighting ...

Doug Long, VP, industry relations, IQVIA, examines shifting pharmaceutical trends, including specialty growth, biosimilar ...

A panel of experts examines how stakeholders can support strategies that improve patient outcomes, while also navigating ...

The afternoon of day 2 at Asembia’s AXS25 Summit offered various intriguing sessions to pick from, including one on ...

The famous trees, and the festival associated with their blossoming each spring, is part of a tradition for the global ...

Chip Parkinson, CEO, GiftHealth, explains how AI, real-time data, and closer payer collaboration are driving the next phase ...

Will Pih, co-founder, Two Labs, explains how specialty pharmacies and manufacturers are adapting to financial pressures in rare disease care through patient-centric services, hub innovation, and ...

IQVIA’s Doug Long offers a lay of the land, including trends and developing issues that are shaping the current market. The second day of Asembia’s AXS25 Summit here in Las Vegas started off with a ...